DMPA-SC was approved and included on the Essential Medicines List in 2018 following its initial pilot. Continued efforts are needed to scale up the provision in 26 states for public and private sector provision, including approval by the Pharmaceutical Council of Nigeria to add it on the Approved Patent Medicines List, state-level adoption of the national rollout plan, product procurement, and trainings to enable community health extension workers, private patent medicine vendors, and community pharmacists to provide DMPA-SC across the country.
Country: